MedPath

STEBA FRANCE

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy

Phase 2
Terminated
Conditions
Prostate Cancer
Interventions
Drug: Treatment with WST09 Vascular Photodynamic therapy
First Posted Date
2006-04-10
Last Posted Date
2010-06-02
Lead Sponsor
STEBA France
Target Recruit Count
16
Registration Number
NCT00312442
Locations
🇨🇦

Princess Margaret Hospital, Toronto, Ontario, Canada

Study of Photodynamic Therapy in Patients With Prostate Cancer Following Radiation Therapy

Phase 2
Completed
Conditions
Recurrent or Persistent Localized Carcinoma of the Prostate Following Radiation Therapy Failure
Interventions
Drug: WST09
First Posted Date
2006-03-30
Last Posted Date
2010-06-22
Lead Sponsor
STEBA France
Target Recruit Count
28
Registration Number
NCT00308919
Locations
🇨🇦

Princess Margaret Hospital, Toronto, Ontario, Canada

Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure

Phase 2
Completed
Conditions
Prostate Cancer
Interventions
Drug: Treatment with Tookad VTP
First Posted Date
2006-03-22
Last Posted Date
2010-06-02
Lead Sponsor
STEBA France
Target Recruit Count
8
Registration Number
NCT00305929
Locations
🇨🇦

The Prostate Centre Princess Margaret Hospital, Toronto, Ontario, Canada

Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers

Phase 1
Completed
Conditions
Esophagitis
Gastroesophageal Reflux
Stomach Ulcer
Duodenal Ulcer
Interventions
Drug: S-Tenatoprazole-Na (STU-Na)
First Posted Date
2006-02-01
Last Posted Date
2008-03-24
Lead Sponsor
STEBA France
Target Recruit Count
32
Registration Number
NCT00284908
Locations
🇺🇸

Healthcare Discoveries, Inc., San Antonio, Texas, United States

Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis

Phase 2
Suspended
Conditions
Esophagitis, Reflux
First Posted Date
2006-01-26
Last Posted Date
2008-03-19
Lead Sponsor
STEBA France
Target Recruit Count
450
Registration Number
NCT00282555
© Copyright 2025. All Rights Reserved by MedPath